Trial Identifier: | D4194R00004 |
Sponsor: | AstraZeneca |
NCTID:: | NCT04068168 |
Start Date: | January 2020 |
Primary Completion Date: | August 2024 |
Study Completion Date: | August 2024 |
Condition: | Lung Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
South Korea | Ansan-si, South Korea, 15355 |
South Korea | Anyang-si, South Korea, 431-070 |
South Korea | Bucheon-si, South Korea, 14647 |
South Korea | Busan, South Korea, 49267 |
South Korea | Busan, South Korea, 49241 |
South Korea | Changwon-si, South Korea, 51353 |
South Korea | Cheonan, South Korea, 330-715 |
South Korea | Daegu, South Korea, 41931 |
South Korea | Daegu, South Korea, 41404 |
South Korea | Goyang-si, South Korea, 10380 |
South Korea | Gwangju, South Korea, 61453 |
South Korea | Gyeonggi-do, South Korea, 11765 |
South Korea | Gyeongsangnam-do, South Korea, 52727 |
South Korea | Gyeongsangnam-do, South Korea, 50612 |
South Korea | Hwasun-gun, South Korea, 58128 |
South Korea | Iksan-si, South Korea, 54538 |
South Korea | Incheon, South Korea, 405-760 |
South Korea | Incheon, South Korea, 21431 |
South Korea | Jeonju-si, South Korea, 54907 |
South Korea | Pohang-si, South Korea, 37816 |
South Korea | Seo-gu, South Korea, 49201 |
South Korea | Seoul, South Korea, 133-792 |
South Korea | Seoul, South Korea, 05505 |
South Korea | Seoul, South Korea, 03722 |
South Korea | Seoul, South Korea, 01812 |
South Korea | Seoul, South Korea, 08308 |
South Korea | Seoul, South Korea, 02447 |
South Korea | Suwon-si, South Korea, 442-723 |
South Korea | Yongin-si, South Korea, 16995 |